Home » Stock Quotes » NYSEAMERICAN:AGE

AgeX Therapeutics, Inc. NYSEAMERICAN:AGE

Today's live share price, quote history, chart & news

Price:
0.79 USD
Change:
-0.08 (-9.20%)
Price open 0.86
Previous close 0.87
Market cap 29.75M
Volume 103.15K
Day high 0.88
Day low 0.78
Year high 4.99
Year low 0.75

About AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc. has a research collaboration with the University of California to develop neural stem cells for use in cell based therapy. The company was incorporated in 2017 and is based in Alameda, California.

Overview
Name AgeX Therapeutics, Inc.
Exchange NYSE American Stock Exchange
Sector Healthcare
Industry Biotechnology
Country United States
Full time employees 17

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.